Diagnostic Quality of Magnetic Resonance Imaging Interpretation for Peripheral Nerve Sheath Tumors: Can Malignancy Be Determined?

Abstract

Background Optimal management of peripheral nerve sheath tumors including neurofibromas, schwannomas, and malignant peripheral sheath tumors (MPNSTs) is predicated on knowing the specific pathology. Magnetic resonance imagining (MRI) has the potential to provide insight in the tumor type, yet imprecision in diagnosis remains. We assessed the accuracy of preoperative imaging diagnoses by comparing them with postoperative histopathologic diagnoses. We specifically focus on erroneous diagnosis of MPNSTs.

Methods We reviewed all pathologically confirmed cases of nerve sheath tumors treated at our institution retrospectively from 2007 to 2015. Pre- and postoperative imaging data were reviewed for imaging-based diagnosis and compared with postresection pathologic diagnosis.

Results The study included 127 patients: 82 diagnosed with neurofibroma, 17 with schwannoma, 24 with MPNST, and 4 with other histology types. A mean age of 40.8 ± 20.4 years, mean tumor size of 4.3 ± 3.6 cm, and mean follow-up of 29.1 ± 21.6 months were recorded. A family history of neurofibromatosis type 1 (NF1) was seen in 58 patients (46%). A discordant diagnosis from preoperative imaging and postoperative pathology was found in 65 individuals (51%). Most discordant diagnoses (n = 34) were inconclusive interpretation of preoperative imaging; however, 10 patients were diagnosed with a benign or unknown lesion on preoperative imaging but had an MPNST on histopathology. Patients with MPNST were more likely than those with benign pathologies to have larger lesions (7.6 ± 4.8 cm versus 3.5 ± 3.3 cm; p = 0.004); however, a statistically acceptable threshold value could not be found to separate benign from malignant lesions. Clinical factors, such as NF1 status, did not meaningfully improve preoperative diagnosis.

Conclusions These results suggest that routine MRI is insufficient to guide surgical decision making reliably. Additional imaging techniques may be necessary to delineate the radiologic features of nerve sheath tumors to determine pathology more precisely.

Keywords

neurofibroma - schwannoma - nerve sheath tumor - MRI

• References

• 1 Boyes J. Bunnell's Surgery of the Hand. Vol 1. Philadelphia, PA: JB Lippincott; 1970
• 2 Butler ED, Hamill JP, Seipel RS, De Lorimier AA. Tumors of the hand. A ten-year survey and report of 437 cases. Am J Surg 1960; 100: 293-302
• 3 Harkin J, Reed R. Fasc. 3. Tumors of the Peripheral Nervous System, Second series. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1969
• 4 Inoue M, Kawano T, Matsumura H, Mori K, Yoshida T. Solitary benign schwannoma of the brachial plexus. Surg Neurol 1983; 20 (2) 103-108
• 5 Stack HG. Tumors of the hand. BMJ 1960; 1 (5177) 919-922
• 6 Strickland JW, Steichen JB. Nerve tumors of the hand and forearm. J Hand Surg Am 1977; 2 (4) 285-291
• 7 Louis DN, Ohgaki H, Wiestler OD , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114 (2) 97-109
• 8 Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002; 39 (5) 311-314
• 9 Maniker A, Gupta G, Guha A. Surgery for malignant peripheral nerve sheath tumors. In: Winn H, ed. Youmans Neurological Surgery, 6th ed. Philadelphia, PA: Elsevier; 2011
• 10 Amrami KK, Felmlee JP, Spinner RJ. MRI of peripheral nerves. Neurosurg Clin N Am 2008; 19 (4) 559-572 , vi
• 11 Singh T, Kliot M. Imaging of peripheral nerve tumors. Neurosurg Focus 2007; 22 (6) E6
• 12 Stull MA, Moser Jr RP, Kransdorf MJ, Bogumill GP, Nelson MC. Magnetic resonance appearance of peripheral nerve sheath tumors. Skeletal Radiol 1991; 20 (1) 9-14
• 13 Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 1997; 27 (2) 124-129
• 14 Levine E, Huntrakoon M, Wetzel LH. Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 1987; 149 (5) 1059-1064
• 15 Li CS, Huang GS, Wu HD , et al. Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging 2008; 32 (2) 121-127
• 16 Ogose A, Hotta T, Morita T , et al. Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol 1999; 28 (4) 183-188
• 17 Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57 (10) 2006-2021
• 18 Kransdorf MJ. Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 1995; 164 (2) 395-402
• 19 Demehri S, Belzberg A, Blakeley J, Fayad LM. Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience. AJNR Am J Neuroradiol 2014; 35 (8) 1615-1620
• 20 Ma LD, Frassica FJ, Scott Jr WW, Fishman EK, Zerbouni EA. Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging. Radiographics 1995; 15 (2) 349-366
• 21 Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 2012; 265 (2) 340-356
• 22 Maeda M, Matsumine A, Kato H , et al. Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient. J Magn Reson Imaging 2007; 25 (6) 1199-1204
• 23 Benz MR, Czernin J, Dry SM , et al. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 2010; 116 (2) 451-458
• 24 Warbey VS, Ferner RE, Dunn JT, Calonje E, O'Doherty MJ. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 2009; 36 (5) 751-757
• 25 Khiewvan B, Macapinlac HA, Lev D , et al. The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging 2014; 41 (9) 1756-1766
• 26 Schöffski P, Deroose CM, Gheysens O , et al. The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I. BMC Med Imaging 2014; 14: 19